Cargando…

Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer

SIMPLE SUMMARY: The survival rates of prostate cancer substantially vary by race and socioeconomic status. Compared with non-Hispanic white men, African American men tend to have a two-fold increased risk of death. Similarly, inferior survival outcomes are found in low-income patients compared to hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baoyi, Li, Jianrong, Tang, Mabel, Cheng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417437/
https://www.ncbi.nlm.nih.gov/pubmed/37568792
http://dx.doi.org/10.3390/cancers15153977
_version_ 1785088035311845376
author Zhang, Baoyi
Li, Jianrong
Tang, Mabel
Cheng, Chao
author_facet Zhang, Baoyi
Li, Jianrong
Tang, Mabel
Cheng, Chao
author_sort Zhang, Baoyi
collection PubMed
description SIMPLE SUMMARY: The survival rates of prostate cancer substantially vary by race and socioeconomic status. Compared with non-Hispanic white men, African American men tend to have a two-fold increased risk of death. Similarly, inferior survival outcomes are found in low-income patients compared to high-income patients. Although such disparities have been extensively investigated in past years, there has still been a lack of studies investigating the trends in these disparities in recent decades. Hence, we analyzed the Surveillance Epidemiology End Results (SEER) data containing 534,076 prostate cancer patients diagnosed from 2004 to 2018. Our study revealed that the racial disparity fluctuated during 2004–2011, following which it substantially reduced. In contrast, the socioeconomic disparity witnessed a consistent increase during 2004–2018. Our findings suggested more efforts were needed to improve the treatment plans for patients with limited financial resources, which may also aid in updating the existing treatment guidelines for prostate cancer. ABSTRACT: Prostate cancer is a cancer type associated with a high level of racial and socioeconomic disparities as reported by many previous studies. However, the changes in these disparities in the past two decades have not been systematically studied. In this study, we investigated the Surveillance Epidemiology End Results (SEER) data for prostate cancer patients diagnosed during 2004–2018. African Americans and Asians showed significantly better and worse cancer-specific survival (CSS), respectively, compared to non-Hispanic white individuals after adjusting for confounding factors such as age and cancer stage. Importantly, the data indicated that racial disparities fluctuated and reached the highest level during 2009–2013, and thereafter, it showed a substantial improvement. Such a change cannot be explained by the improvement in early diagnosis but is mainly driven by the differential improvement in CSS between races. Compared with Asians and non-Hispanic whites, African American patients achieved a more significant survival improvement during 2014–2018, while no significant improvement was observed for Hispanics. In addition, the SEER data showed that high-income patients had significantly longer CSS than low-income patients. Such a socioeconomic disparity was continuously increasing during 2004–2018, which was caused by the increased survival benefits of the high-income patients with respect to the low-income patients. Our study suggests that more efforts and resources should be allocated to improve the treatment of patients with low socioeconomic status.
format Online
Article
Text
id pubmed-10417437
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-104174372023-08-12 Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer Zhang, Baoyi Li, Jianrong Tang, Mabel Cheng, Chao Cancers (Basel) Article SIMPLE SUMMARY: The survival rates of prostate cancer substantially vary by race and socioeconomic status. Compared with non-Hispanic white men, African American men tend to have a two-fold increased risk of death. Similarly, inferior survival outcomes are found in low-income patients compared to high-income patients. Although such disparities have been extensively investigated in past years, there has still been a lack of studies investigating the trends in these disparities in recent decades. Hence, we analyzed the Surveillance Epidemiology End Results (SEER) data containing 534,076 prostate cancer patients diagnosed from 2004 to 2018. Our study revealed that the racial disparity fluctuated during 2004–2011, following which it substantially reduced. In contrast, the socioeconomic disparity witnessed a consistent increase during 2004–2018. Our findings suggested more efforts were needed to improve the treatment plans for patients with limited financial resources, which may also aid in updating the existing treatment guidelines for prostate cancer. ABSTRACT: Prostate cancer is a cancer type associated with a high level of racial and socioeconomic disparities as reported by many previous studies. However, the changes in these disparities in the past two decades have not been systematically studied. In this study, we investigated the Surveillance Epidemiology End Results (SEER) data for prostate cancer patients diagnosed during 2004–2018. African Americans and Asians showed significantly better and worse cancer-specific survival (CSS), respectively, compared to non-Hispanic white individuals after adjusting for confounding factors such as age and cancer stage. Importantly, the data indicated that racial disparities fluctuated and reached the highest level during 2009–2013, and thereafter, it showed a substantial improvement. Such a change cannot be explained by the improvement in early diagnosis but is mainly driven by the differential improvement in CSS between races. Compared with Asians and non-Hispanic whites, African American patients achieved a more significant survival improvement during 2014–2018, while no significant improvement was observed for Hispanics. In addition, the SEER data showed that high-income patients had significantly longer CSS than low-income patients. Such a socioeconomic disparity was continuously increasing during 2004–2018, which was caused by the increased survival benefits of the high-income patients with respect to the low-income patients. Our study suggests that more efforts and resources should be allocated to improve the treatment of patients with low socioeconomic status. MDPI 2023-08-04 /pmc/articles/PMC10417437/ /pubmed/37568792 http://dx.doi.org/10.3390/cancers15153977 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Baoyi
Li, Jianrong
Tang, Mabel
Cheng, Chao
Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title_full Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title_fullStr Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title_full_unstemmed Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title_short Reduced Racial Disparity as a Result of Survival Improvement in Prostate Cancer
title_sort reduced racial disparity as a result of survival improvement in prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417437/
https://www.ncbi.nlm.nih.gov/pubmed/37568792
http://dx.doi.org/10.3390/cancers15153977
work_keys_str_mv AT zhangbaoyi reducedracialdisparityasaresultofsurvivalimprovementinprostatecancer
AT lijianrong reducedracialdisparityasaresultofsurvivalimprovementinprostatecancer
AT tangmabel reducedracialdisparityasaresultofsurvivalimprovementinprostatecancer
AT chengchao reducedracialdisparityasaresultofsurvivalimprovementinprostatecancer